[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kwong et al., 1986 - Google Patents

Analysis of digoxin at therapeutic concentrations using high-performance liquid chromatography with post-column derivatization

Kwong et al., 1986

Document ID
6487300343849065576
Author
Kwong E
McErlane K
Publication year
Publication venue
Journal of Chromatography B: Biomedical Sciences and Applications

External Links

Snippet

A high-performance liquid chromatographic (HPLC) procedure has been developed for the analysis of digoxin in plasma at therapeutic concentrations. The assay method provides resolution of digoxin from its metabolites using a 15 cm× 4.6 mm HPLC column containing 3 …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor

Similar Documents

Publication Publication Date Title
Ross et al. GC-MS analysis of the total δ9-thc content of both drug-and fiber-type cannabis seeds
Israel et al. Liquid chromatographic analysis of adriamycin and metabolites in biological fluids
Wilson et al. A gas chromatography-mass spectrometry method for the quantitative analysis of melatonin in plasma and cerebrospinal fluid
Thompson et al. Determination of δ9-tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection
Umans et al. Determination of heroin and its metabolites by high-performance liquid chromatography
Koçyiğit-Kaymakçoğlu et al. Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography
Erdtmansky et al. Gas-liquid chromatographic electron capture determination of some monosubstituted guanido-containing drugs
Mays et al. Improved method for the determination of aspirin and its metabolites in biological fluids by high-performance liquid chromatography: applications to human and animal studies
Peat et al. The screening and quantitation of diazepam, flurazepam, chlordiazepoxide, and their metabolites in blood and plasma by electron-capture gas chromatography and high pressure liquid chromatography
Gill et al. Analysis of barbiturates in blood by high-performance liquid chromatography
Kabra et al. A simultaneous high-performance liquid chromatographic analysis of the most common anticonvulsants and their metabolites in the serum
Kwong et al. Analysis of digoxin at therapeutic concentrations using high-performance liquid chromatography with post-column derivatization
Plum et al. Detection of digoxin, digitoxin, their cardioactive metabolites and derivatives by high-performance liquid chromatography and high-performance liquid chromatography—radioimmunoassay
Robieux et al. Determination of unbound etoposide concentration in ultrafiltered plasma by high-performance liquid chromatography with fluorimetric detection
Englert Jr et al. A rapid, new and direct method for isolation and measurement of porphyrins in biological samples by high performance liquid chromatography
Herring et al. Simple method for determination of terbutaline plasma concentration by high-performance liquid chromatography
Bartlett et al. Bioanalysis of cimetidine by high-performance liquid chromatography
Nicot et al. Ion-pair extraction and high-performance liquid chromatographic determination of tianeptine and its metabolites in human plasma, urine and tissues
Wallace et al. Determination of promethazine in serum by liquid chromatography.
Alburges et al. Profiles of Δ9-tetrahydrocannabinol metabolites in urine of marijuana users: preliminary observations by high performance liquid chromatography-radioimmunoassay
Walshe et al. Comparison of two extraction methods for determination of propranolol and furosemide in human plasma by mixed-mode chromatography
Badcock et al. Micro-determination of clonazepam in plasma or serum by electron-capture gas—liquid chromatography
Adams Specific and sensitive high performance liquid chromatographic determination of alprazolam or triazolam
Wong An evaluation of HPLC for the screening and quantitation of benzodiazepines and acetaminophen in post mortem blood
Molnar et al. Separation of urinary aromatic acids and measurement of vanilmandelic acid by high-performance liquid chromatography